TipRanks
Go Ultimate55% OFF

Ipsidy (8KZ0) AI Stock Analysis

DE:8KZ0

Ipsidy

(Frankfurt:8KZ0)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
High Gross MarginThe exceptionally high gross margin indicates that the core offering can generate substantial contribution from each unit of revenue. If the company restores growth and controls operating expenses, this underlying economics could support meaningful operating leverage and future profitability.
Negative Factors
Sharp Revenue ContractionA roughly 43% TTM revenue decline signals weakening commercial traction and makes the company’s fixed operating base harder to support. Unless demand and customer adoption recover, the contraction can prolong losses, reduce funding flexibility, and undermine the scalability of the identity platform.

Ipsidy (8KZ0) vs. iShares MSCI Germany ETF (EWG)

-100%-80%-60%-40%-20%0%20%DE:8KZ0-88.86%EWG+4.43%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
EUR 4.41M
Dividend Yield
―
Average Volume (3M)
16.52K
Price to Earnings (P/E)
-0.2
Beta (1Y)
0.88
Revenue Growth
-44.65%
EPS Growth
25.04%
Country
Germany
Employees
46
Sector
Technology
Sector Strength
61
Industry
Software - Infrastructure

Ipsidy Business Overview & Revenue Model

Company Description

authID Inc. operates a global Identity as a Service (IDaaS) platform, delivering a comprehensive suite of secure, mobile-friendly, and biometric identity solutions. This platform enables users to verify and authenticate their identity via a mobile de...

Ipsidy Earnings Call Summary

Earnings Call Date:May 13, 2026(Q1-2026)|% Change Since:-76.60%|Next Earnings Date:May 13, 2026
Earnings Call SentimentNeutral

The call presents meaningful operational and technological progress — notably a differentiated quantum-resistant biometric platform, a high-quality pipeline (~20 enterprise POCs), ARR growth and planned $3.5M annualized cost savings — and financing steps that extend runway. However, material risks remain: revenue is still small in absolute terms, net losses and adjusted EBITDA deficits persist, cash on hand was low at ~$1.2M (mitigated by a $4.2M bridge loan), RPO declined sequentially, and a substantial portion of newly booked ARR is estimated usage rather than firm commitments. The outlook depends heavily on converting enterprise POCs into production contracts over the coming quarters.

Positive Updates

Revenue Growth
Total revenue for Q1 2026 was approximately $480,000 versus $296,000 in Q1 2025, a year-over-year increase of approximately 62%.

Negative Updates

Small Absolute Revenue Base
Despite 62% YoY growth, total Q1 revenue remains modest at ~$480,000, indicating revenue scale is still limited and dependent on converting large enterprise POCs.

Company Guidance

Management's guidance emphasized near‑term financial stabilization and pipeline conversion: beginning in Q2 2026 the company initiated cost cuts expected to yield approximately $3.5 million of annualized savings (realized through the remainder of 2026 and into 2027) and secured ~ $4.2 million of Bridge Financing in late April to extend runway; Q1 results cited as context were revenue of ~ $480,000 (up ~62% YoY from $296,000), operating expenses of $5.0 million, net loss of $4.5 million (noncash charges ~ $1.0 million) and net loss per share of $0.28, adjusted EBITDA loss of $3.4 million (improved from $3.9M a year ago), cash on hand of ~ $1.2 million and cash used in operations of ~ $3.4 million (vs $5.4M prior year); they reported RPO of $2.0 million (down from $2.2M in Q4) but expect RPO growth in H2 2026 as roughly 20 active POCs (pipeline described as “more than a dozen,” nearly half sourced via channel partners) convert in Q2–Q4 2026, complementing ARR of $1.9 million (up from $1.2M year‑ago) and Q1 gross bARR of $0.08 million (38% cARR / 62% UAC) toward the goal of reaching cash‑flow sustainability.

Ipsidy Risk Analysis

Ipsidy disclosed 31 risk factors in its most recent earnings report. Ipsidy reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Ipsidy Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

DE:8KZ0 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JGJG67Neutral$39.23M44.289.31%―14.88%―
Sector *61Neutral$37.18B12.37-10.20%1.83%8.50%-7.62%
INTZINTZ41Neutral$14.27M-1.06-187.84%―-15.22%34.74%
BNAIBNAI40Underperform$31.37M-1.63-0.25%―706.94%68.10%

* Technology Sector Average

Performance Comparison

0%500%1000%DE:8KZ0JGINTZBNAICISODec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
DE:8KZ0 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:8KZ0Ipsidy Inc.0.23-1.99-89.46%
JGAurora Mobile6.54-0.63-8.79%
INTZIntrusion0.58-1.27-68.54%
BNAIBrand Engagement Network Inc.4.19-0.46-9.89%
CISOCerberus Cyber Sentinel Corporation0.17-0.93-84.27%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.